To study the 
Gene amplification in mammalian cells is a phenomenon originally discovered in murine cells selected to become highly resistant to methotrexate (1) . It has later been shown to occur in many different genes both in cell culture and in natural tumors, and it was proposed to be a contributor to tumorigenesis (2, 3) . In cultured mammalian cells, gene amplification frequency is much higher in transformed cells than in primary cells (4, 5) , and higher in cells with relaxed cell cycle checkpoint control than in cells with stringent cell cycle checkpoint control (6) . Cells without functional p53 protein (homozygous deletion or mutation) amplify genes much more readily than cells with wild-type p53 (7, 8) . The inherent amplification frequency of each cell line can be increased by treatment with hydroxyurea, aphidicolin, and many other agents, most of which are DNA synthesis inhibitors (9) (10) (11) (12) .
Since dihydrofolate reductase (DHFR) gene amplification can be detected by isolating cells with higher DHFR content by using the fluorescence-activated cell sorter (13) , it is generally assumed that the stress imposed on the cells by the selecting agents does not induce gene amplification, but rather selects for existing amplification at the locus responsible for the resistance to the selecting agent. However, the effect of pretreatment with DNA synthesis inhibitors indicates that gene amplification can be enhanced by the stress caused by these agents. Among the possible consequences of these agents
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are DNA misreplication and breakage (14) . Almost '-------- Cell Biology: Yin and Schimke ·~I1)))SSy ".L. (Fig. 2A) . The variation of average DHFR amplification among the pooled resistant cells prompted us to study five individual clones of TMTX-resistant BH2 cells selected with or without tetracycline in the medium, respectively. Genomic DNA was extracted from these clones and DHFR amplification was detected by slot blots (Fig. 2B) Proc. Natl. Acad. Sci. USA 93 (1996) A Apc treatment, hr 0 0 0 0 0 0 0 0 0 0 1212 2424 blotting ( Fig. 2A, last four lanes) . Again, DHFR amplification appeared responsible for all the TMTX resistance. resistant HeLa S3 cells (6) . Blots a and b were probed with the DHFR-specific probe; blots c and d were probed with the MDRspecific probe.
(9-12). We therefore studied the effect of Bcl-2 overexpression on the frequency of gene amplification in BH2 cells pretreated with aphidicolin at 2 /ug/ml for various times. The results are summarized in Table 2 (Table 1) . This is consistent with our previous finding that there is significant clonogenic heterogeneity in a given cell line (24) . Studies P53 deficiency has been reported to increase gene amplification frequency (7, 8) and also inhibit apoptosis (27, 28) . Therefore, at least part of the effect of p53 on gene amplification frequency may be due to its effect on cell death.
The effect of Bcl-2 on the prognosis for human cancer patients is paradoxically inconsistent. While Bcl-2 expression is associated with poor prognosis and poor response to chemotherapy in acute myeloid leukemia (29) , large-cell lymphoma (30) , and prostate cancer (31) , it does not affect, or slightly improves, the prognosis for breast cancer (32, 33) . Our results indicate that Bcl-2 delays the commitment into apoptosis with one treatment (TMTX), but only delays the onset of apoptosis with another treatment (aphidicolin) (17) . Therefore, the effect of Bcl-2 on long-term cell survival under drug treatment may not be uniform. Because Bcl-2 increases the frequency of TMTX resistance by delaying the commitment to apoptosis and allowing a longer time window for gene amplification, Bcl-2 could affect oncogenesis through its secondary effect on genome stability and gene amplification.
